CareTrust REIT (CTRE) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

CareTrust REIT

NYSE•Real Estate•REIT - Healthcare Facilities

$38.42+0.31(0.01%)After hours

Market Cap

$8.92B

P/E

25.1x

P/S

15.6x

P/B

2.0x

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a portfolio of long-term net-leased properties spanning the United States and United Kingdom, and a growing portfolio of quality operators leasing them, CareTrust is pursuing both external and organic growth opportunities across the US and internationally. CareTrust REIT, Inc. was established in 2013 and was incorporated in Maryland.

How this company scores

GoodMetricSide Score: 67/100

Strongest: Growth (22/25); weakest: Cash & Earnings Quality (6/25).

Profitability18/25

Growth22/25

Balance Sheet & Red Flags21/25

Cash & Earnings Quality6/25

Strengths

Growing revenueStrong marginsRising earningsLow leverage

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 25.1x5y range 24.4x – 238.5x

Currently below its 18-quarter median.

P/S · 15.6x5y range 8.8x – 18.3x

Currently near its 20-quarter median.

P/B · 2.0x5y range 1.4x – 2.4x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Earnings Quality

Red Flag

Free cash flow has been negative in 4 of the last 8 quarters — earnings are not translating to cash.

Cash Burn

Watch

4 of the last 8 quarters had negative FCF — inconsistent cash generation raises sustainability concerns.

Price & Volume

Market Cap $8.92B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $571.43M
Q. Revenue: $161.35M
TTM EBITDA: $431.67M
TTM Op. Income: $318.04M
Q. Op. Income: $88.97M
TTM Net Income: $355.40M
Q. Net Income: $89.00M
EPS: $0.38
Shares Out.: $233.75M

$571.43M in TTM revenue grew 53.0% YoY, reaching $161.35M last quarter. TTM EBITDA of $431.67M and TTM operating income of $318.04M show growth is flowing through to the bottom line. TTM net income of $355.40M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 74.0%
Op. Margin: 55.1%
Net Margin: 55.2%

Op. margin of 55.1% is down 0.5% YoY — costs are rising relative to revenue. Net margin at 55.2% Over the past year, operating margin is down 1% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 25.1x
P/S Ratio: 15.6x
P/B Ratio: 2.0x

At 25.1x P/E, the stock trades within typical market levels. P/S of 15.6x and P/B of 2.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 6% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.93B
Cash: $47.59M
Long-Term Debt: $1.21B
Book Value: $4.49B
D/E Ratio: 0.3
Debt/EBITDA: 10.1

With $5.93B in assets and $1.21B in long-term debt, D/E is 0.3and book value is $4.49B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 23% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $134.75M
TTM Free Cash Flow: $-337.73M
FCF Margin: -59.1%
FCF / Net Income: -1.0

TTM FCF of $-337.73M on $134.75M in operating cash flow. The FCF / Net Income ratio of -1.0x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is up 70% — an improving trend.